IBBQ icon

Invesco NASDAQ Biotechnology ETF

9 hedge funds and large institutions have $15.9M invested in Invesco NASDAQ Biotechnology ETF in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

Holders
9
Holders Change
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Mirae Asset Global Investments
1
Mirae Asset Global Investments
South Korea
$7.44M 313,596
Bank of America
2
Bank of America
North Carolina
$3.56M 150,000 -250,000 -63%
Citigroup
3
Citigroup
New York
$2.37M 100,000 -300,000 -75%
Morgan Stanley
4
Morgan Stanley
New York
$1.19M 50,000 -300,000 -86%
CGL
5
Clarius Group LLC
Washington
$445K 18,752
AF
6
Apexium Financial
Texas
$431K 18,178 +18,178 New
TRCT
7
Tower Research Capital (TRC)
New York
$417K 17,566 +8,182 +87%
AIP
8
Ahrens Investment Partners
Louisiana
$9K 400 +400 New
UBS Group
9
UBS Group
Switzerland
$8K 349 +349 New
JPMorgan Chase & Co
10
JPMorgan Chase & Co
New York
-238,777 Closed
FTUS
11
Flow Traders U.S.
New York
-20,000 Closed
Osaic Holdings
12
Osaic Holdings
Arizona
-200 Closed
CFGS
13
Concourse Financial Group Securities
Alabama